Efficacy and tolerability of levetiracetam (LEV) as add-on treatment in refractory epileptic patients with partial onset seizures: Analysis of the crossover part of the European trial.

Shorvon, S.;Otoul, C.;Selak, I.
(1999)

Files

document.pdf
  • Restricted Access
  • Adobe PDF
  • 546.97 KB

Details

Authors
  • Shorvon, S.
    Author
  • Otoul, C.
    Author
  • Selak, I.
    Author
Affiliations

Citations

Shorvon, S., Otoul, C., & Selak, I. (1999). Efficacy and tolerability of levetiracetam (LEV) as add-on treatment in refractory epileptic patients with partial onset seizures: Analysis of the crossover part of the European trial. Epilepsia, 40, 248-249. https://doi.org/10.1111/j.1528-1157.1999.tb02083.x (Original work published 1999)